Undisclosed CLDN18.2 targeted masked TCE - Xilio Therap
Undisclosed STEAP1 targeted masked TCE - Xilio Therap
Undisclosed PSMA targeted masked TCE - Xilio Therap
https://www.globenewswire.com/news-release/2025/11/07/3183720/0/en/Xilio-Therapeutics-Highlights-Portfolio-of-Differentiated-Masked-Immunotherapies-at-Society-for-Immunotherapy-of-Cancer-SITC-40th-Annual-Meeting.html
 
Nov 7, 2025
 
Next